Celestial Biolabs logo

CELESTIAL - Celestial Biolabs Share Price

₹1.75 0.0  0.0%

Last Trade - 11/03/20

Consumer Defensives
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £3.71m
Position in Universe th / 3030
Unlock CELESTIAL Revenue
Relative Strength (%)
1m -36.8%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
235 274.5 328.6 386.6 428.1 489.7 +15.8%
+1.0 +42.5 +31.7 +60.5 -0.3
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 30 June 2019, CelestialBiolabs Limited revenues decreased 74% to RS42.7M. Net losstotaled RS10M vs. income of RS12.7M. Revenues reflect adecrease in demand for the Company's products and servicesdue to unfavorable market conditions. Net loss reflectsDepreciation and Amortization increase of 15% to RS22.2M(expense), Finance Cost increase from RS5K to RS1.4M(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


CELESTIAL Revenue Unlock CELESTIAL Revenue

Net Income

CELESTIAL Net Income Unlock CELESTIAL Revenue

Normalised EPS

CELESTIAL Normalised EPS Unlock CELESTIAL Revenue

PE Ratio Range

CELESTIAL PE Ratio Range Unlock CELESTIAL Revenue

Dividend Yield Range

CELESTIAL Dividend Yield Range Unlock CELESTIAL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CELESTIAL EPS Forecasts Unlock CELESTIAL Revenue
Profile Summary

Celestial Biolabs Limited is an India-based biopharmaceutical company. The Company is engaged in the production and supply of herbal and feed supplement formulations. The Company's products portfolio includes health products for men, women and children. Its product categories include herbal, enzymes and nutraceuticals. Its herbal product category includes products, such as proprietary products and classical products. Proprietary products include Biovita, Cadalmin GAe, Cel-Digest, Bioliv, Rhumacel, Cel-Clear, Biopower Gold, Bio-Dnorm, Dermacel, Gynocel, Healthone, Relifin and C-Kaps. Its Classical products include Lavan Bhaskar Churna, Talishadi Churna, Sitopaladi Churna, Sring Bhasma, Bala Chaturbhadrika Churna and Chandraprabha Vat. Its enzymes products include CELZYME-P, CELZYME-L, CELZYME-PMAX, CELZYME-DMAX, CELZYME-OXI, CELZYME-TEXDS, CELZYME-TEXWASH, CELZYME-DSB, CELZYME-Peroxide, CELZYME-RECASE, CELZYME-Phytase, CELZYME-CELCAF, CELZYME-Maxmol and CELZYME-Amyl.

Last Annual March 31st, 2019
Last Interim June 30th, 2019
Incorporated November 19, 1997
Public Since July 22, 2007
No. of Shareholders: n/a
No. of Employees: n/a
Sector Consumer Defensives
Industry Food & Tobacco
Exchange National Stock Exchange of India
Shares in Issue 22,586,350
Free Float (0.0%)
Eligible for
CELESTIAL Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CELESTIAL
Upcoming Events for CELESTIAL
Frequently Asked Questions for Celestial Biolabs
What is the Celestial Biolabs share price?

As of 11/03/20, shares in Celestial Biolabs are trading at ₹1.75, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Celestial Biolabs share price performed this year?

Shares in Celestial Biolabs are currently trading at ₹1.75 and the price has moved by -71.54% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Celestial Biolabs price has moved by -73.34% over the past year.

What are the analyst and broker recommendations for Celestial Biolabs?

Of the analysts with advisory recommendations for Celestial Biolabs, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Celestial Biolabs is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Celestial Biolabs next release its financial results?

Celestial Biolabs is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-06-30
What is the Celestial Biolabs dividend yield?

Celestial Biolabs does not currently pay a dividend.

Does Celestial Biolabs pay a dividend?

Celestial Biolabs does not currently pay a dividend.

When does Celestial Biolabs next pay dividends?

Celestial Biolabs does not currently pay a dividend.

How do I buy Celestial Biolabs shares?

To buy shares in Celestial Biolabs you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Celestial Biolabs?

Shares in Celestial Biolabs are currently trading at ₹1.75, giving the company a market capitalisation of £n/a.

Where are Celestial Biolabs shares listed? Where are Celestial Biolabs shares listed?

Here are the trading details for Celestial Biolabs:

Country of listing: India
Exchange: NSI
Ticker Symbol: CELESTIAL
What kind of share is Celestial Biolabs?

We were not able to load our ranking data for Celestial Biolabs

Is there a Celestial Biolabs share price forecast 2020?

We were not able to load any forecast data for Celestial Biolabs.

How can I tell whether the Celestial Biolabs share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Celestial Biolabs. Over the past six months, the relative strength of its shares against the market has been -62.51%. At the current price of ₹1.75, shares in Celestial Biolabs are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Celestial Biolabs PE Ratio?

We were not able to find PE ratio data for Celestial Biolabs.

Who are the key directors of Celestial Biolabs?

Celestial Biolabs's management team is headed by:

Aditya Singh - CHM
Padma Singh - NED
Jeetainder Gour - NED
B. Siva Kumar - NID
P. Ramakrishna - CCO
Who are the major shareholders of Celestial Biolabs?

Here are the top five shareholders of Celestial Biolabs based on the size of their shareholding:

Singh (Aditya Narayan) Individual Investor
Percentage owned: 12.2% (2.76m shares)
Singh (Padma) Individual Investor
Percentage owned: 5.19% (1.17m shares)
Singh (Nitin Kumar) Individual Investor
Percentage owned: 4.63% (1.05m shares)
Subramanian (P) Individual Investor
Percentage owned: 4.04% (912k shares)
Singh (Amit Kumar) Individual Investor
Percentage owned: 3.38% (764k shares)
Similar to CELESTIAL
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.